ZA200203269B - Nucleic acids of the human ABC1 gene and their therapeutic and diagnostic application. - Google Patents

Nucleic acids of the human ABC1 gene and their therapeutic and diagnostic application.

Info

Publication number
ZA200203269B
ZA200203269B ZA200203269A ZA200203269A ZA200203269B ZA 200203269 B ZA200203269 B ZA 200203269B ZA 200203269 A ZA200203269 A ZA 200203269A ZA 200203269 A ZA200203269 A ZA 200203269A ZA 200203269 B ZA200203269 B ZA 200203269B
Authority
ZA
South Africa
Prior art keywords
therapeutic
nucleic acids
diagnostic application
abc1 gene
human abc1
Prior art date
Application number
ZA200203269A
Other languages
English (en)
Inventor
Patrice Denefle
Isabelle Arnould-Reguigne
Laurent Naudin
Nicolas Duverger
George H Searfoss Iii
H Bryan Brewer
Marie-Francoise Rosier-Montus
Catherine Prades
Cendrine Lemoine
Michael Jaye
Alan Remaley
Michael Dean
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ZA200203269B publication Critical patent/ZA200203269B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
ZA200203269A 1999-10-26 2002-04-24 Nucleic acids of the human ABC1 gene and their therapeutic and diagnostic application. ZA200203269B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99402668A EP1096012A1 (fr) 1999-10-26 1999-10-26 Acides nucléiques correspondant au gène ABC1 humain et leur application thérapeutique et diagnostique

Publications (1)

Publication Number Publication Date
ZA200203269B true ZA200203269B (en) 2003-07-24

Family

ID=8242152

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203269A ZA200203269B (en) 1999-10-26 2002-04-24 Nucleic acids of the human ABC1 gene and their therapeutic and diagnostic application.

Country Status (8)

Country Link
EP (2) EP1096012A1 (fr)
JP (1) JP2003523177A (fr)
AU (1) AU1391901A (fr)
BR (1) BR0014998A (fr)
CA (1) CA2388950A1 (fr)
HU (1) HUP0400492A3 (fr)
WO (1) WO2001030848A2 (fr)
ZA (1) ZA200203269B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821774B1 (en) 1999-06-18 2004-11-23 Cv Therapeutics, Inc. Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
US6835563B1 (en) 1999-06-18 2004-12-28 Cv Therapeutics Compositions and methods for increasing cholesterol efflux and raising HDL ATP binding cassette transporter protein ABC1
WO2001070810A2 (fr) * 2000-03-20 2001-09-27 Bayer Aktiengesellschaft Polymorphismes geniques de transporteur 1 de cassettes de liaison d'atp (abc1) et utilisations de ceux-ci dans le diagnostic et le traitement de troubles lipidiques, de maladies cardio-vasculaires et de maladies inflammatoires
WO2002036770A2 (fr) * 2000-10-31 2002-05-10 Aventis Pharma S.A. Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
WO2005116057A1 (fr) * 2004-05-27 2005-12-08 Baker Medical Research Institute Anticorps monoclonal dirigé contre le gène abca1
WO2006061646A1 (fr) * 2004-12-11 2006-06-15 The Science And Technology Facilities Council Dosage pour produire un profil lipidique au moyen d'une mesure de fluorescence
EP2037740A4 (fr) * 2006-06-07 2011-12-28 Reddys Lab Ltd Dr Compositions et procédés d'amélioration du transport inverse du cholestérol
US20220411880A1 (en) * 2019-11-21 2022-12-29 Inserm (Institut National De La Santéet De La Recherche Médicale) Methods and compositions for diagnosing and treating chronic myelomonocytic leukemia (cmml)

Also Published As

Publication number Publication date
EP1096012A1 (fr) 2001-05-02
HUP0400492A2 (hu) 2004-05-28
EP1257651A2 (fr) 2002-11-20
CA2388950A1 (fr) 2001-05-03
HUP0400492A3 (en) 2006-01-30
WO2001030848A3 (fr) 2002-09-12
WO2001030848A2 (fr) 2001-05-03
JP2003523177A (ja) 2003-08-05
BR0014998A (pt) 2003-06-17
AU1391901A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
GB9516947D0 (en) Modulators of body weight,corresponding nucleic acids and proteins,and diagnostic and therapeutic uses thereof
NZ289028A (en) Use of antisense nucleic acids in the treatment of skin disease
IL152981A0 (en) Infusion of liquids into the human or animal body
WO1999033998A3 (fr) Sequences d'adn regulatrices du gene de la sous-unite telomerase catalytique humaine et leur utilisation a des fins diagnostiques et therapeutiques
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002303261A8 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
ZA200203269B (en) Nucleic acids of the human ABC1 gene and their therapeutic and diagnostic application.
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU6092900A (en) Animals comprising human hepatocellular tissue
AU3247201A (en) Gene therapy to promote angiogenesis and/or the treatment of heart failure
AU1490801A (en) Targeted delivery of therapeutic and diagnostic moieties
PL362867A1 (en) Human heparanase-related polypeptide and nucleic acid
AP2781A (en) Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechansim, from the use of these porteins or from the inhibition thereof
EP1220896A4 (fr) Nouvelles proteines lipase humaines, acides nucleiques codant pour ces proteines, et leur utilisation
IL149185A0 (en) Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application
GB9908059D0 (en) Diagnosis and treatment of diseases
IL147071A0 (en) Nucleic and proteinic acids corresponding to human gene abc1
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
WO2001014415A3 (fr) Gènes egfh2 et produits géniques
AU5876899A (en) Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
AU2001245693A1 (en) Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
AU2002222308A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular response
AU2002303262A1 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof
AU5760200A (en) Human genes and proteins encoded thereby
IL133342A0 (en) Electrostatic stimulation of the human body